Shanghai, China

Xianting Ding

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 5.6

ph-index = 1


Company Filing History:


Years Active: 2018-2025

Loading Chart...
Loading Chart...
3 patents (USPTO):

Title: Xianting Ding: Innovator in Microfluidics and Tuberculosis Treatment

Introduction

Xianting Ding, an accomplished inventor based in Shanghai, China, has made significant contributions to the field of biomedical engineering. With three patents to his name, Ding's work focuses on advancing medical technologies, particularly in the areas of microfluidics and tuberculosis treatment.

Latest Patents

Among his recent inventions, Ding's microfluidic chip and its manufacturing method stand out. This innovative chip is designed to facilitate the separation of circulating tumor cells from cell samples. The device features a first unit for channeling the sample and a second unit that captures single cells for further analysis. Notably, the chip enables the binding of a protein molecule with an antibody after lysing the single cells. Additionally, Ding has developed a method for treating tuberculosis, which leverages a combination of drug compounds to enhance therapeutic efficacy.

Career Highlights

Xianting Ding has collaborated with notable institutions such as the University of California and Water Bear Health Technology (Nantong) Co., Ltd. His inventive pursuits reflect a dedication to improving healthcare outcomes through technology.

Collaborations

Ding has had the opportunity to work alongside esteemed colleagues, including Chih-Ming Ho and Daniel L. Clemens. Their joint efforts exemplify the power of collaboration in driving innovation forward.

Conclusion

With a strong foundation in patenting innovative technologies, Xianting Ding continues to pave the way for advancements in medical research and applications. His contributions are significant not only to the field of microfluidics but also to the broader medical community's fight against diseases like tuberculosis.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…